Moreover, we conducted in vitro experiments to prove that, exogenous overexpression of GBP5 in T cells fails to augment their tumor-killing efficacy, while elevated GBP5 expression in OC cells does not directly enhance the secretion of GZMB and IFNγ from T cells. The gene discussed is GBP5; the disease is neoplasm.